Gold Silver Reports (GSR) -Sun Pharma Gains After Receiving FDA Approval For ILUMYA — Shares of the country’s largest drug maker rose as much as 3.3 percent, the most in a month, to Rs 521.
The pharmaceutical company received a green signal from the U.S. drug regulator ILUMYA, used to treat moderate-to-severe plaque psoriasis, according to its stock exchange notification.
Trading volume was 2.6 times its 20-day average. The stock declined 10 percent so far this year.
